MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

03 Feb 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 03 February 2021, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Topiramate Extended?Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’ which is self? explanatory

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1777.60
Dr. Reddys Labs. 1190.10
Cipla 1316.50
Lupin 2001.20
Zydus Lifesciences 1122.00
View more..